Tables of diseases, risk factors, xenobiotic sensitivities associated with mutations in genes of the superfamily

Diseases

DiseaseGene_locusNum of mutationsOMIM
Anti-Dipeptidyl-Peptidase-Like Protein 6 (DPPX) Encephalitis Progressive Encephalomyelitis with Rigidity and Myoclonushuman-DPP6 0 126141, 616311
Chanarin-Dorfman syndromehuman-ABHD5 44 275630, 604780
Congenital absence of pancreatic lipasehuman-PNLIP 10 246600, 614338
Craniotubular dysplasia, Ikegawa type (CTDI)human-TMEM53 2 619722, 619727
Familial hypercholanemiahuman-BAAT, human-EPHX1 3 602938, 607748
Galactosialidosishuman-CTSA 25 256540, 613111
Gilles de la Tourette syndrome (GTS)human-DPP6 1 126141, 137580
Goiter, familial with hypothyroidism, autosomal recessivehuman-TG 98 188450, 274700
Hatipoglu syndromehuman-DPP9 4 608258, 620331
Hepatic triglyceride lipase Deficiencyhuman-LIPC 12 125853, 151670, 246650, 612797, 614025
Hereditary motor and sensory neuropathy, LOM Typehuman-NDRG1 8 601455, 605262
Hereditary spastic paraplegia (HSP) ABHD16Ahuman-ABHD16A 9 142620, 619735
Hyperlipoproteinemia TypeIhuman-LPL 167 238600, 246650, 609708
Hypobetalipoproteinemia Familial 2human-LIPC 1 151670, 605019
Hypotonia-Cystinuria Syndromehuman-PREPL 10 606407, 609557
Hypotrichosishuman-LIPH 32 604379, 607365
Infantile neuronal ceroid lipofuscinosishuman-PPT1 73 256730, 600722
Late-Onset Form of Autosomal-Recessive Congenital Ichthyosishuman-LIPN 1 613924, 613943
Lecithin-cholesterol acyltransferase deficiency (LCATD) and fish-eye disease (FED)human-LCAT 91 136120, 245900, 606967
Lipoatrophic diabeteshuman-EPHX1 2 132810, 32810
Lipodystrophy, familial partial, type 6human-LIPE 3 151750, 615980
MEGDEL syndromehuman-SERAC1 27 614725, 614739
Mast Syndromehuman-SPG21 7 248900, 608181
Maturity-onset diabetes of the Young, Type8, with exocrine dysfunction, MODY8human-CEL 8 114840, 609812
Mental retardation, autosomal dominant 33human-DPP6 3 126141, 616311
Mental retardation, autosomal recessive 42 MRT42human-PGAP1 9 611655, 615802
Myasthenic syndrome, congenital, 22; CMS22human-PREPL 12 609557, 616224
NAFLDhuman-ABHD5 2 604780
Neuro-ocular DAGLA-related syndromehuman-DAGLA 7 614015
Neuroligin 1 Alzheimer's disease (AD) Autismhuman-NLGN1 5 600568, 618830
Neuroligin 2 Suceptibility Schizophrenia, anxiety, autism, intellectual disability, hyperphagia, and obesityhuman-NLGN2 2 606479
Neuroligin 3 Autism AUTSX1 Asperger syndrome ASPGX1human-NLGN3 4 300336, 300425
Neuroligin 4 Autism AUTSX2 Asperger syndrome ASPGX2human-NLGN4X, human-NLGN4Y 12 300425, 300427, 300495
PHARC Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracthuman-ABHD12 18 612674, 613599
Parkinson disease, autosomal recessive (ARPD) early-onset (EOPD)human-DAGLB 4 614016
Suceptibility to asthma and atopy, Platelet-activating factor acetylhydrolase (PLA2G7) deficiency (PAFAD) coronary artery disease risk factorhuman-PLA2G7 9 147050, 600807, 601690, 614278
Susceptibility to Hypertriglyceridemiahuman-LIPI 1 145750, 609252
Ventricular fibrillation, paroxysmal familial 2human-DPP6 1 126141, 612956
Wolman disease WD, Cholesterol Ester Storage Disease, CESDhuman-LIPA 66 278000, 613497
pulmonary atresia with ventricular septal defect (PA/VSD) and tetralogy of Fallot (TOF)human-NDRG4 1 178370, 614463




Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer